SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-767770
Filing Date
2016-11-14
Accepted
2016-11-14 16:02:20
Documents
53
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d271002d10q.htm 10-Q 515979
2 EX-31.1 d271002dex311.htm EX-31.1 9200
3 EX-31.2 d271002dex312.htm EX-31.2 9197
4 EX-32.1 d271002dex321.htm EX-32.1 5433
  Complete submission text file 0001193125-16-767770.txt   2618486

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aldx-20160930.xml EX-101.INS 405681
6 XBRL TAXONOMY EXTENSION SCHEMA aldx-20160930.xsd EX-101.SCH 32835
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aldx-20160930_cal.xml EX-101.CAL 39752
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aldx-20160930_def.xml EX-101.DEF 90438
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aldx-20160930_lab.xml EX-101.LAB 276949
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aldx-20160930_pre.xml EX-101.PRE 183325
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 161994681
SIC: 2834 Pharmaceutical Preparations